Symbols / BIVI Stock $1.40 +3.70% BioVie Inc.

Healthcare • Biotechnology • United States • NCM
BIVI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Cuong Viet Do M.B.A.
Exch · Country NCM · United States
Market Cap 10.56M
Enterprise Value -2.62M
Income -19.96M
Sales —
FCF (ttm) -14.26M
Book/sh 2.07
Cash/sh 1.74
Employees 13
Insider 10d —
IPO Sep 18, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.32
PEG —
P/S —
P/B 0.68
P/C —
EV/EBITDA 0.13
EV/Sales —
Quick Ratio 9.02
Current Ratio 9.97
Debt/Eq 1.90
LT Debt/Eq —
EPS (ttm) -3.79
EPS next Y -4.41
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-11
Earnings (prior) 2026-05-11
ROA -61.04%
ROE -106.43%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 7.54M
Shs Float 7.50M
Insider Own 0.36%
Instit Own 13.94%
Short Float 2.36%
Short Ratio 2.49
Short Interest 177.09K
52W High 12.10
vs 52W High -88.43%
52W Low 1.06
vs 52W Low 32.08%
Beta —
Impl. Vol. —
Rel Volume 0.41
Avg Volume 78.37K
Volume 32.51K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $1.35
Price $1.40
Change 3.70%
About

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.40
Latest analyst target
3. DCF / Fair value
$-34.03
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.40
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-07-01 init ThinkEquity — → Buy $3
2023-11-30 main Oppenheimer Outperform → Outperform $5
2023-08-22 reit Cantor Fitzgerald Overweight → Overweight $11
2023-07-18 reit Cantor Fitzgerald Overweight → Overweight $11
2023-05-17 reit Cantor Fitzgerald Overweight → Overweight $11
2023-05-17 reit Oppenheimer Outperform → Outperform $12
2023-02-14 reit Oppenheimer — → Outperform $12
2022-09-28 main EF Hutton — → Buy $8
2022-07-22 init Cantor Fitzgerald — → Overweight $7
2022-03-17 main EF Hutton — → Buy $14
2022-03-15 init Oppenheimer — → Outperform $9
2021-11-30 main B. Riley Securities — → Buy $27
2021-01-15 init B. Riley FBR — → Buy $47
News
RSS: Latest BIVI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-08-07 DO CUONG VIET Chief Executive Officer — 5,000 $2.91 $14,550
2024-11-20 ROGICH SIGMUND A Director — 32,700 $0.00 $0
2024-11-20 BERMAN RICHARD JAY Director — 34,200 $0.00 $0
2024-06-24 DO CUONG VIET Chief Executive Officer — 168,000 $0.00 $0
2024-06-24 KIM JOANNE WENDY Chief Financial Officer — 73,000 $0.00 $0
2024-06-24 PALUMBO JOSEPH M Officer — 116,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
18.07
-43.86%
32.18
-28.62%
45.08
+65.41%
27.25
Research And Development
9.27
-59.88%
23.10
-30.63%
33.30
+92.95%
17.26
Selling General And Administration
8.57
-3.16%
8.85
-23.39%
11.55
+18.29%
9.77
Total Expenses
18.07
-43.86%
32.18
-28.62%
45.08
+65.41%
27.25
Operating Income
-18.07
+43.86%
-32.18
+28.62%
-45.08
-65.41%
-27.25
Total Operating Income As Reported
-18.07
+43.86%
-32.18
+28.62%
-45.08
-65.41%
-27.25
EBITDA
-16.98
+41.44%
-29.00
+36.59%
-45.73
-93.00%
-23.69
Normalized EBITDA
-16.98
+44.88%
-30.81
+30.43%
-44.29
-64.16%
-26.98
Reconciled Depreciation
0.23
+0.00%
0.23
+0.00%
0.23
+0.00%
0.23
EBIT
-17.21
+41.12%
-29.23
+36.40%
-45.96
-92.11%
-23.92
Total Unusual Items
0.00
-99.79%
1.82
+226.35%
-1.44
-143.73%
3.29
Total Unusual Items Excluding Goodwill
0.00
-99.79%
1.82
+226.35%
-1.44
-143.73%
3.29
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Net Income
-17.54
+45.39%
-32.12
+36.09%
-50.26
-92.67%
-26.08
Pretax Income
-17.54
+45.39%
-32.12
+36.09%
-50.26
-92.67%
-26.08
Net Non Operating Interest Income Expense
0.52
+129.61%
-1.76
+52.99%
-3.74
-76.41%
-2.12
Interest Expense Non Operating
0.33
-88.50%
2.89
-32.70%
4.30
+98.81%
2.16
Net Interest Income
0.52
+129.61%
-1.76
+52.99%
-3.74
-76.41%
-2.12
Interest Expense
0.33
-88.50%
2.89
-32.70%
4.30
+98.81%
2.16
Interest Income Non Operating
0.85
-24.96%
1.14
+102.17%
0.56
+1175.55%
0.04
Interest Income
0.85
-24.96%
1.14
+102.17%
0.56
+1175.55%
0.04
Other Income Expense
0.00
-99.79%
1.82
+226.35%
-1.44
-143.73%
3.29
Gain On Sale Of Security
0.00
-99.79%
1.82
+226.35%
-1.44
-143.73%
3.29
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-17.54
+45.39%
-32.12
+36.09%
-50.26
-92.67%
-26.08
Net Income From Continuing Operation Net Minority Interest
-17.54
+45.39%
-32.12
+36.09%
-50.26
-92.67%
-26.08
Net Income From Continuing And Discontinued Operation
-17.54
+45.39%
-32.12
+36.09%
-50.26
-92.67%
-26.08
Net Income Continuous Operations
-17.54
+45.39%
-32.12
+36.09%
-50.26
-92.67%
-26.08
Normalized Income
-17.55
+48.30%
-33.94
+30.48%
-48.82
-66.21%
-29.37
Net Income Common Stockholders
-17.91
+45.73%
-33.01
+34.32%
-50.26
-92.67%
-26.08
Otherunder Preferred Stock Dividend
0.37
-58.32%
0.89
0.00
0.00
Diluted EPS
-12.12
+83.41%
-73.05
+52.78%
-154.70
-45.94%
-106.00
Basic EPS
-12.12
+83.41%
-73.05
+52.78%
-154.70
-45.94%
-106.00
Basic Average Shares
1.48
+226.96%
0.45
+39.10%
0.32
+31.71%
0.25
Diluted Average Shares
1.48
+226.96%
0.45
+39.10%
0.32
+31.71%
0.25
Diluted NI Availto Com Stockholders
-17.91
+45.73%
-33.01
+34.32%
-50.26
-92.67%
-26.08
Amortization
0.23
+0.00%
0.23
+0.00%
0.23
+0.00%
0.23
Amortization Of Intangibles Income Statement
0.23
+0.00%
0.23
+0.00%
0.23
+0.00%
0.23
Depreciation Amortization Depletion Income Statement
0.23
+0.00%
0.23
+0.00%
0.23
+0.00%
0.23
Depreciation And Amortization In Income Statement
0.23
+0.00%
0.23
+0.00%
0.23
+0.00%
0.23
Line Item Trend 2025-06-30 2024-06-30 2023-06-30
Total Assets
21.56
-14.46%
25.21
-28.19%
35.10
Current Assets
20.70
-13.93%
24.05
-29.36%
34.04
Cash Cash Equivalents And Short Term Investments
17.54
-26.42%
23.84
-29.74%
33.94
Cash And Cash Equivalents
17.54
-26.42%
23.84
+22.52%
19.46
Cash Equivalents
13.57
+22.44%
11.08
-15.78%
13.16
Cash Financial
3.98
-68.83%
12.76
+102.46%
6.30
Other Short Term Investments
—
0.00
-100.00%
14.48
Receivables
2.10
0.00
—
Other Receivables
2.10
—
—
Prepaid Assets
—
—
—
Other Current Assets
1.05
+413.67%
0.20
+99.36%
0.10
Total Non Current Assets
0.86
-25.55%
1.16
+9.08%
1.06
Net PPE
0.34
-16.49%
0.41
+403.44%
0.08
Gross PPE
0.34
-16.49%
0.41
+403.44%
0.08
Properties
0.00
0.00
0.00
Buildings And Improvements
0.34
-16.49%
0.41
+403.44%
0.08
Other Properties
—
—
0.08
Goodwill And Other Intangible Assets
0.52
-30.44%
0.75
-23.34%
0.98
Goodwill
0.35
+0.00%
0.35
+0.00%
0.35
Other Intangible Assets
0.18
-56.26%
0.41
-36.00%
0.64
Other Non Current Assets
—
—
—
Total Liabilities Net Minority Interest
2.55
-73.71%
9.70
-50.91%
19.76
Current Liabilities
2.27
-75.68%
9.35
-35.48%
14.49
Payables And Accrued Expenses
2.20
-38.66%
3.59
+3.18%
3.48
Current Debt And Capital Lease Obligation
0.07
-98.71%
5.76
-37.03%
9.15
Current Debt
—
5.70
-37.38%
9.11
Other Current Borrowings
—
5.70
-37.38%
9.11
Current Capital Lease Obligation
0.07
+23.40%
0.06
+34.37%
0.04
Other Current Liabilities
—
0.00
-99.80%
1.87
Total Non Current Liabilities Net Minority Interest
0.28
-21.28%
0.35
-93.36%
5.27
Long Term Debt And Capital Lease Obligation
0.28
-21.28%
0.35
-93.36%
5.27
Long Term Debt
—
—
5.23
Long Term Capital Lease Obligation
0.28
-21.28%
0.35
+723.18%
0.04
Other Non Current Liabilities
—
—
—
Stockholders Equity
19.01
+22.61%
15.51
+1.08%
15.34
Common Stock Equity
19.01
+22.61%
15.51
+1.08%
15.34
Capital Stock
0.01
+20.02%
0.01
+70.99%
0.00
Common Stock
0.01
+20.02%
0.01
+70.99%
0.00
Preferred Stock
0.00
0.00
0.00
Share Issued
1.92
+208.39%
0.62
+70.54%
0.36
Ordinary Shares Number
1.91
+209.24%
0.62
+69.92%
0.36
Treasury Shares Number
0.00
+7.79%
0.00
+1054.39%
0.00
Additional Paid In Capital
371.15
+6.12%
349.73
+10.54%
316.39
Retained Earnings
-352.14
-5.36%
-334.23
-10.96%
-301.23
Gains Losses Not Affecting Retained Earnings
—
0.00
-100.00%
0.18
Treasury Stock
0.00
+7.41%
0.00
+1250.00%
0.00
Other Equity Adjustments
—
—
0.18
Total Equity Gross Minority Interest
19.01
+22.61%
15.51
+1.08%
15.34
Total Capitalization
19.01
+22.61%
15.51
-24.61%
20.57
Working Capital
18.42
+25.37%
14.70
-24.82%
19.55
Invested Capital
19.01
-10.35%
21.21
-28.53%
29.67
Total Debt
0.35
-94.27%
6.11
-57.62%
14.42
Capital Lease Obligations
0.35
-14.71%
0.41
+369.30%
0.09
Net Tangible Assets
18.49
+25.32%
14.75
+2.75%
14.36
Tangible Book Value
18.49
+25.32%
14.75
+2.75%
14.36
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
-19.03
+31.92%
-27.95
+30.58%
-40.25
-111.96%
-18.99
Cash Flow From Continuing Operating Activities
-19.03
+31.92%
-27.95
+30.58%
-40.25
-111.96%
-18.99
Net Income From Continuing Operations
-17.54
+45.39%
-32.12
+36.09%
-50.26
-92.67%
-26.08
Depreciation Amortization Depletion
0.23
+0.00%
0.23
+0.00%
0.23
+0.00%
0.23
Amortization Cash Flow
0.23
+0.00%
0.23
+0.00%
0.23
+0.00%
0.23
Depreciation And Amortization
0.23
+0.00%
0.23
+0.00%
0.23
+0.00%
0.23
Amortization Of Intangibles
0.23
+0.00%
0.23
+0.00%
0.23
+0.00%
0.23
Other Non Cash Items
0.22
-84.72%
1.41
-36.67%
2.23
+84.88%
1.21
Stock Based Compensation
2.47
-46.96%
4.66
-26.90%
6.38
+2.93%
6.19
Operating Gains Losses
-0.00
+99.82%
-2.04
-241.92%
1.44
+143.73%
-3.29
Gain Loss On Investment Securities
-0.00
+99.82%
-2.04
-241.92%
1.44
+143.73%
-3.29
Change In Working Capital
-4.40
-4962.57%
-0.09
+67.89%
-0.27
-109.83%
2.75
Change In Receivables
-2.10
0.00
—
—
Change In Prepaid Assets
-0.85
-730.02%
-0.10
-355.21%
0.04
+181.54%
-0.05
Change In Payables And Accrued Expense
-1.39
-1353.10%
0.11
-89.29%
1.03
-28.55%
1.45
Change In Other Current Assets
—
—
—
-0.05
Change In Other Current Liabilities
-0.06
+36.90%
-0.10
+92.88%
-1.34
-199.30%
1.35
Investing Cash Flow
0.00
-100.00%
14.53
+201.57%
-14.30
0.00
Cash Flow From Continuing Investing Activities
0.00
-100.00%
14.53
+201.57%
-14.30
0.00
Net Investment Purchase And Sale
0.00
-100.00%
14.53
+201.57%
-14.30
0.00
Purchase Of Investment
—
—
-14.30
0.00
Sale Of Investment
0.00
-100.00%
14.53
—
—
Financing Cash Flow
12.73
-28.52%
17.80
-67.85%
55.37
+67.18%
33.12
Cash Flow From Continuing Financing Activities
12.73
-28.52%
17.80
-67.85%
55.37
+67.18%
33.12
Net Issuance Payments Of Debt
-5.85
0.00
0.00
-100.00%
14.61
Issuance Of Debt
—
—
0.00
-100.00%
14.61
Repayment Of Debt
-5.85
0.00
0.00
0.00
Long Term Debt Issuance
—
—
0.00
-100.00%
14.61
Long Term Debt Payments
—
-10.00
0.00
0.00
Net Long Term Debt Issuance
—
-10.00
0.00
-100.00%
14.61
Short Term Debt Issuance
—
—
—
14.61
Short Term Debt Payments
-5.85
0.00
—
—
Net Short Term Debt Issuance
-5.85
0.00
—
14.61
Net Common Stock Issuance
15.67
-43.62%
27.80
-49.79%
55.37
+199.12%
18.51
Proceeds From Stock Option Exercised
2.90
+129.01%
-10.00
-446528.57%
0.00
0.00
Changes In Cash
-6.30
-243.72%
4.38
+435.05%
0.82
-94.20%
14.13
Beginning Cash Position
23.84
+22.52%
19.46
+4.39%
18.64
+313.19%
4.51
End Cash Position
17.54
-26.42%
23.84
+22.52%
19.46
+4.39%
18.64
Free Cash Flow
-19.03
+31.92%
-27.95
+30.58%
-40.25
-111.96%
-18.99
Interest Paid Supplemental Data
0.18
-87.94%
1.53
-27.60%
2.11
+118.46%
0.96
Income Tax Paid Supplemental Data
—
—
—
0.00
Common Stock Issuance
15.67
-43.62%
27.80
-49.79%
55.37
+199.12%
18.51
Issuance Of Capital Stock
15.67
-43.62%
27.80
-49.79%
55.37
+199.12%
18.51
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category